Gout is the most common form of inflammatory arthritis, and it is characterized by the deposition of monosodium urate crystals that form in the presence of increased uric acid concentrations. A high serum uric acid concentration (hyperuricemia) is frequently associated with gout. The burden of gout has increased between 1990 and 2017 globally. In Japan, most of gout patients are adults, and the number of gout patients are higher in men than in women. The prevalence of gout has increased markedly since the 1960s. The Japanese Society of Gout and Uric & Nucleic Acids has stated that an increase in hyperuricemia and gout patients is attributed to changes in environmental factors (e.g., purine intake, fructose intake, meat and visceral intake, alcohol consumption, strenuous muscle exercise, stress, obesity) rather than genetic factors. The Japanese economy revived to pre-World War II levels around 1955 and the eating habits in 1960s became stable. The menu of Japanese food has been rapidly expanded with a variety of dishes due to the westernization of meals from 1955 to 1965. Compared to the Japanese diet in 1950, in the Japanese diet in 2016, consumption of rice and potatoes decreased, whereas intake of wheat, legumes, seeds and nuts, seaweed, vegetables, fruit, meat, seafood, eggs, milk and dairy products, oils and fats, seasoning and spices increased. This phenomenon is thought to be attributed to the westernization of the Japanese diet since 1955. Recognizing changes in the Japanese diet are important for dietary habits modification to prevent gout in Japanese people. The objective of this article is to propose a preventive method for gout through the evaluation of recent dietary habits in Japanese people. This article suggests that changes in the Japanese diet are possible to be one of the factors contributing to the increase in the number of gout patients in Japan.
| Published in | American Journal of Health Research (Volume 9, Issue 5) |
| DOI | 10.11648/j.ajhr.20210905.12 |
| Page(s) | 117-127 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Comorbidities of Gout, Dietary Habits, Food, Gout, Hyperuricemia, The Japanese Diet, Uric Acid
| [1] | Doherty, M. (2009) New insights into epidemiology of gout. Rheumatology. (Oxford), 48 (suppl 2), ii2-ii8. |
| [2] | Lin, K-M., Lu, C-L., Hung, K-C., Wu, P-C., Pan, C-F., Wu, C-J., Syu, R-S., Chen, J-S., Hsiao, P-J., & Lu, K-C. (2019) The paradoxical role of uric acid in osteoporosis. Nutrients, 11, 2111. |
| [3] | Jakše, B., Jakše, B., Pajek, M., & Pajek, J. (2019) Uric acid and plant-based nutrition. Nutrients, 11, 1736. |
| [4] | Zychowcz, M. E. (2011) Gout: No longer the disease of kings. Orthop Nurs, 30, 322-330. |
| [5] | MacFariane, L. A. (2014) Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin N Am, 40, 581-604. |
| [6] | El Ridi, R., & Tallima, H. (2017) Physiological functions and pathogenic potential of uric acid: A review. J Adv Res, 8, 487-493. |
| [7] | Itakura, M. (2009) Metabolic pathway and regulation of uric acid production. Hyperuricemia and Gout, 17, 106-111. |
| [8] | Taniguchi, A., & Kamatani, N. (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol, 20, 192-197. |
| [9] | Fabbrini, E., Serafini, M., Colic Baric, C., Hazen, S. L., & Klein, S. (2014) Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes, 63, 976-981. |
| [10] | Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA, 78, 6858-6862. |
| [11] | De Becker, B., Borghi, C., Bumier, M., & van de Borne, P. (2019) Uric acid hypertension: a focused review and practical recommendations. J Hypertens, 37, 878-883. |
| [12] | Stocker, R., &Keaney, J. F. Jr. (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev, 84, 1381-1478. |
| [13] | Fang, P., Li, X., Luo, J. J., Wang, H., & Yang, X-F. (2013) A Double-edged sword: uric acid and neurological disorders. Brain Disord Ther, 2, 109. |
| [14] | Tana, C., Ticinesi, A., Prati, B., Nouvenne, A., & Meschi, T. (2018) Uric acid and cognitive function in older individuals. Nutrients, 10, 975. |
| [15] | Lippi, G., Montagnana, M., Franchini, M., Favaloro, E. J., & Targher, G. (2008) The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta, 392, 1-7. |
| [16] | Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M., &Galaris, D. A. (2005) Uric acid and oxidative stress. Curr Pharm Des, 11, 4145-4151. |
| [17] | Bagnati, M., Perugini, C., Cau, C., Bordone, R., Albano, E., &Bellomo, G. (1999) When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J, 340. 143-152. |
| [18] | Ruggiero, C., Cherubini, A., Ble, A., Bos, A. J., Maggio, M., Dixit, V. D., Lauretani, F., Bandinelli, S., Senin, U., & Ferrucci, L. (2006) Uric acid and inflammatory markers. Eur Heart J, 27, 1174-1181. |
| [19] | Dalbeth, N., Merrriman, T. R., & Stamp, L. K. (2016) Gout. Lancet, 388, 2039-2052. |
| [20] | Zhu, Y., Pandya, B. J., & Choi, H. K. (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum, 63, 3136-3141. |
| [21] | Kuo, C. F., Grainge, M. J., Zhang, W., & Doherty, M. (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol, 11, 649-662. |
| [22] | Mikanagi, K. (1963) Gout in Japan. The Kyosai Medical Journal, 12, 14-37 (in Japanese). |
| [23] | Nishioka, K., Mikanagi, K., & Hirose, K. (1974) Clinical study of gout and hyperuricemia: Epidemiology and pathogenesis. Rheum, 14, 95-105. |
| [24] | Ministry of Agriculture, Forestry and Fisheries. (2020) Japanese food culture textbook [Internet]. Available from: https://www.maff.go.jp/j/keikaku/syokubunka/culture/eiyo.html. |
| [25] | The Ministry of Agriculture, Forestry and Fisheries. (2020) WASHOKU, traditional dietary cultures of the Japanese [Internet]. Available from: https://www.maff.go.jp/e/japan_food/washoku/pdf/wasyoku_english.pdf. |
| [26] | Yanagimoto, M. (2004) Statistical analysis of the direction in which the food consumption pattern in Japan was advancing. Nippon Shokuhin Kagaku Kogaku Kaishi, 51, 524-530 (in Japanese). |
| [27] | Feig, D. I., Kang, D-H., & Johnson, R. J. (2008) Uric acid and cardiovascular risk. N Engl J Med, 359, 1811-1821. |
| [28] | Zhu, Y., Pandya, B. J., & Choi, H. K. (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med, 125, 679-687. |
| [29] | Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., Kaldas, M., Gogia, M., Perez-Ruiz, F., Taylor, W., Lioté, F., Choi, H., Singh, J. A., Dalbeth, N., Kaplan, S., Niyyar, V., Jones, D., Yarows, S. A., Roessler, B., Kerr, G., King, C., Levy, G., Furst, D. E., Edwards, N. L., Mandell, B., Schumacher, H. R., Robbins, M., Wenger, N., & Terkeltaub, R. (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Research, 64, 1431-1446. |
| [30] | Choi, H. K. (2010) A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol, 22, 165-172. |
| [31] | Koguchi, T. (2018) Essentials of dietary habits for prevention and suppression of hyperuricemia. Curr Top Pharmacol, 22, 77-133. |
| [32] | Kagan, A., Harris, B. R., Winkelstein, W. Jr., Johnson, K. G., Kato, H., Syme, S. L., Rhoads, G. G., Gay, M. L., Nichaman, M. Z., Hamilton, H. B., & Tillotson, J. (1974) Epidemiologic studies on coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis, 27, 345-364. |
| [33] | Hisatome, I., Ichida, K., Mineo, I., Ohtahara, A., Ogino, K., Kuwabara, M., Ishizaka, N., Uchida, S., Kurajoh, M., Kohagura, K., Sato, Y., Taniguchi, A., Tsuchihashi, T., Terai, C., Nakamura, T., Hamaguchi, T., Hamada, T., Fujimori, S., Masuda, I., Moriwaki, Y., Yamamoto, T. on behalf of guideline development group. (2018) Japanese Society of Gout and Uric & Nucleic Acids Guidelines for Management of Hyperuricemia and Gout: 3 rd edition. SHINDAN TO CHIRYO SHA, Inc. pp. 1-169. Tokyo (in Japanese). |
| [34] | The Ministry of Health, Labour and Welfare. Household Statistics Office. (2020) Comprehensive Survey of Living Conditions [Internet]. Available from: https://www.mhlw.go.jp/toukei/list/20-21kekka.html. |
| [35] | The Ministry of Health, Labour and Welfare. Health Service Bureau. (2020) National Health and Nutrition Survey Japan, 1946-2017 [Internet]. Available from: https://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html. |
| [36] | Guo, Z., Zhang, J., Wang, Z., Ang, K. Y., Huang, S., Hou, Q., Su, X., Qiao, J., Zheng, Y., Wang, L., Koh, E., Danliang, H., Xu, J., Lee, Y. K., & Zhang, H. (2016) Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep, 6, 20602. |
| [37] | Desai, J., Steiger, S., & Anders, H. J. (2017) Molecular pathophysiology of gout. Trends Mol Med, 23, 756-768. |
| [38] | So, A. K., & Martinon, F. (2017) Inflammation in gout: mechanism and therapeutic targets. Nat Rev Rheumatol, 13, 639-647. |
| [39] | Choi, H. K., Mount, D. B., Reginato, A. M., American College of Physicians; American Physiological Society (2005) Pathogenesis of gout. Ann Intern Med, 143, 499-516. |
| [40] | Pittman, J. R., & Bross, M. H. (1999) Diagnosis and management of gout. Am Fam Physician, 59, 1799-1806. |
| [41] | Roman, Y. M. (2019) Perspectives on the epidemiology of gout and hyperuricemia. Hawaii J Med Public Health, 78, 71-76. |
| [42] | Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gil, S. R., Nelson, K. E., & Relman, D. A. (2005) Diversity of the human intestinal microbial flora. Science, 308, 1635-1638. |
| [43] | Wei, B., Dalwadi, H., Gordon, L. K., Landers, C., Bruckner, D., Targan, S. R., & Braun, J. (2001) Molecular cloning of a Bacteroides caccae Tonβ-linked outer membrane protein identified by an inflammatory bowel disease marker antibody. Infect Immun, 69, 6044-6054. |
| [44] | Duskin-Bitan, H., Cohen, E., Goldberg, E., Shochat, T., Levi, A., Garty, M., & Krause, I. (2014) The degree of asymptomatic hyperuricemia and the risk of gout: A retrospective analysis of a large cohort. Clin Rheumatol, 33, 549-553. |
| [45] | Dalbeth, N., Phipps-Green, A., Rrampton, C., Neogi, T., Taylor, W., & Merriman, T. R. (2018) Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis, 77, 148-1052. |
| [46] | Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J. Coyfish, M., Guillo, S., Jansen, T., Janssens, H., Lioté, F., Mallen, C. D., Nuki, G., Perez-Ruiz, F., Pimentao, J., Punzi, L., Pywell, A., So, A., Tausche, A. K., Uhlig, T., Zavada, J., Zhang, W., Tubach, F., & Bardin, T. (2020) 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis, 79, 31-38. |
| [47] | Campion, E. W., Glynn, R. J., & DeLabry, L. O. (1987) Asymptomatic hyperuricemia: Risks and consequences in the Normative Aging Study. Am J Med, 82, 421-426. |
| [48] | Nishioka, K., & Mikanagi, K. (1980) Hereditary and environmental factors influencing on the serum uric acid throughout ten years population study in Japan. Adv Exp Med Biol, 122A, 155-159. |
| [49] | Vedder, D., Walrabenstein, W., Heslinga, M., de Vries, R., Nurmohamed, M., van Schaardenburg, D., & Gerritsen, M. (2019) Dietary interventions for gout and effect on cardiovascular risk factors: A systematic review. Nutrients, 11, 2955. |
| [50] | Elfishawi, M. M., Zleik, N., Kvrgic, Z., Michet, C. J. Jr., Crowson, C. S., Matteson, E. L., & Bongartz, T. (2020) Changes in the presentation of incident gout and the risk of subsequent flares: a population-based study over 20 years. J Rheumatol, 47, 613-618. |
| [51] | Corry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) Uric acid stimulates vascular smooth muscle cell proliferation oxidative stress via the vascular renin-angiotensin system. J Hypertens, 26, 269-275. |
| [52] | Yu, M-A., Sánchez-Lozada, L. G., Johnson, R. J., & Kang, D-H. (2010) Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens, 28, 1234-1242. |
| [53] | Sautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol, 293, C584-596. |
| [54] | Hayden, M. R., & Tyagi, S. C. (2004) Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond), 1, 10. |
| [55] | Yahfoufi, N., Alsadi, N., Jambi, M., & Matar, C. (2018) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients, 10, 1618. |
| [56] | Xia, Y., Wu, Q., Wang, H., Zhang, S., Jiang, Y., Gong, T., Xu, X., Chang, Q., Niu, K., & Zhao, Y. (2020) Global, regional and national burden of gout:, 1990-2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford), 59, 1529-1538. |
| [57] | Smith, E., Hoy, D., Cross, M., Merriman, T. R., Vos, T., Buchbinder, R., Woolf, A., & March, L. (2014) The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis, 73, 1470-1476. |
| [58] | Singh, G., Lingala, B., & Mithal, A. (2019) Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology (Oxford), 58, 2177-2180. |
| [59] | Chen-Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H., & Choi, H. K. (2019) Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol, 71, 991-999. |
| [60] | Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis, 74, 661-667. |
| [61] | Rai, S. K., Aviña-Zubieta, J. A., McComick, N., De Vera, M. A., Shojania, K., Sayre, E. C., & Choi, H. K. (2017) The rising prevalence and incidence of gout in British Columbia, Canada: population-based trends from 2000 to 2012. Semin Arthritis Rheum, 46, 451-456. |
| [62] | Dehlin, M., Drivelegka, P., Sigurdardottir, V., Svard, A., & Jacobsson, L. T. H. (2016) Incidence and prevalence of gout in western Sweden. Arthritis Res Ther, 18, 164. |
| [63] | Castro, K. E., Corey, K. D., Raymond, D. L., Jiroutek, M. R., & Holland, M. A. (2018) An evaluation of gout visits in the United States for the years 2007 to 2011. BMC Rheumatology, 2, 14. |
| [64] | GBD 2017 Diet Collaborators. (2019) Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 393, 1958-1972. |
| [65] | Kawasaki, T., & Shichikawa, K. (2006) Epidemiological survey of gout by resident examination. Gout and nucleic acid metabolism, 30, 66. |
| [66] | Oshima, Y. (1965) Clinical studies on Japanese gout. J Jpn Soc Int Med, 54, 291-310 (in Japanese). |
| [67] | Akizuki, S. (1982) A population study of hyperuricemia and gout in Japan: analysis of sex, age and occupational differences in thirty-four thousand people living in Nagano prefecture. Ryumachi, 22, 201-208 (in Japanese). |
| [68] | Shichikawa, K. (1979) Epidemiology of gout. Internal medicine seminar MET4 Gout. pp. 31-41. Nagai Shoten Co., Ltd. Osaka. |
| [69] | Yamanaka, H., & Kamatani, N. (2002) Gout. J Jpn Soc Int Med, 91, 116-122. |
| [70] | Kawasaki, T. (2007) Epidemiology of gout. Rheumatoid arthritis seminar XVIII (Shichikawa, K., ed.), pp. 51-57. Nagai Shoten Co., Ltd. Osaka. |
| [71] | Hakoda, M., & Kasagi, F. (2018) Trends in gout and hyperuricemia in Japan. Gout and nucleic acid metabolism, 42, 110 (in Japanese). |
| [72] | Hakoda, M, & Kasagi, F. (2020) Future trends for the number of gout patients in Japan. Gout and Uric & Nucleic Acids, 44, 33-39. |
| [73] | Hakoda, M., & Kasagi, F. (2019) Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in in Japan. Med Rheumatol, 29, 880-884. |
| [74] | Bhole, V., de Vera, M., Rahman, M., Krishnan, E., & Choi, H. (2010) Epidemiology of gout in women: fifty-two-year follow-up of a prospective cohort. Arthritis Rheum, 62, 1069-1076. |
| [75] | Hak, A. E., Curhan, G. C., Grodstein, F., & Choi, H. K. (2010) Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis, 69, 1305-1309. |
| [76] | Yamanaka, H., Sakuyama, R., Watanabe, J., Kamatani, N., & Kashiwazaki, S. (1994) Gout in females and in younger ages-current view-. Hyperuricemia and gout, 2, 23-30 (in Japanese). |
| [77] | Ooyama, H., Ooyama, K., Moromizato, H., & Fujimori, S. (2020) Recent trend in onset age of gout in Japan. Gout and Uric & Nucleic Acids, 44, 159-166. |
| [78] | Voruganti, V. S., Laston, S., Haack, K., Mehta, N. R., Cole, S. A., Butte, N. F., & Comuzzie, A. G. (2015) Serum uric acid concentrations and SLC2A9 genetic variation in Hispapanic children: the Viva La Familia Study. Am J Clin Nutr, 101, 725-732. |
| [79] | Wang, W., & Krishnan, E. (2015) Cigarette smoking is associated with a reduction in the risk of incident gout: results from the Framingham Heart study original cohort. Rheumatology, 54, 91-95. |
| [80] | Gee Teng, G., Pan, A., Yuan, J. M., & Koh, W. P. (2016) Cigarette smoking and the risk of incident gout in a prospective cohort study. Arthritis Care Res, 68, 1135-1142. |
| [81] | Burke, B. T., Köttgen, A., Law, A., Windham, B. G., Segev, D., Baer, A. N., Coresh, J., & McAdams-DeMarco, M. A. (2015) Physical function, hyperuricemia, and gout in older adults. Arthritis Care Res (Hoboken), 67, 1730-1738. |
| [82] | Chandratre, P., Roddy, E., Clarson, L., Richardson, J., Hider, S. L., & Mallen, C. D. (2013) Health-related quality of life in gout: a systematic review. Rheumatology, 52, 2031-2040. |
| [83] | Lee, Y-Y., Kuo, L-N., Chen, J-H., Lin, Y-C., Chen, L-F., & Ko, Y. (2019) Prescribing patterns and healthcare costs of gout. Curr Med Res Opin, 35, 1051-1058. |
| [84] | Punzi, L., Scanu, A., Spinella, P., Galozzi, P., & Oliviero, F. O. (2019) One year in review 2018: gout. Clin Exp Rheumatol, 37, 1-11. |
| [85] | Singh, J. A. (2013) Racial and gender disparities among patients with gout. Current Rheumatology Reports, 15, 307. |
| [86] | Reginato, A. M., Mount, D. B., Yang, I., & Choi, H. K. (2012) The genetics of hyperuricemia and gout. Nat Rev Rheumatol, 8, 610-621. |
| [87] | Kolz, M., Johnson, T., Sanna, S., Teumer, A., Vitart, V., Perola, M., Mangino, M., Albrecht, E., Wallace, C., Farrall, M., Johansson, A., Nyholt, D. R., Aulchenko, Y., Beckmann, J. S., Bergmann, S., Bochud, M., Brown, M., Campbell, H., EUROSPAN Consortium; Connell, J., Dominiczak, A., Homuth, G., Lamina, C., McCarthy, M. I., ENGAGE Consortium; Meitinger, T., Mooser, V., Munroe, P., Nauck, M., Peden, J., Prokisch, H., Salo, P., Salomaa, V., Samani, N. J., Schlessinger, D., Uda, M., Völker, M. U., Waeber, G., Waterworth, D., Wang-Sattler, R., Wright, A. F., A., Adamski, J., Whitfield, J. B., Gyllensten, U., Wilson, J. F., Rudan, I., Pramstaller, P., Watkins, H., PROCARDIS Consortium; Doering, A., Wichmann, H-E., KORA Study; Spector, T. D., Peltonen, L., Völzke, H., Nagaraja, R., Vollenweider, P., Caulfield, M., WTCCC; Illig, T., & Gieger, C. (2009) Meta-analysis of 28,141 individuals identifies common variants within five new influence uric acid concentration. PLoS Genet, 5, e1000504. |
| [88] | Lloyd, A., & Burchett, I. (1998) Broadsheet number 43: The role of the laboratory in the investigation and management of hyperuricemia. Pathology, 30, 141-146. |
| [89] | Bardin, T., & Richette, P. (2017) Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Medicine, 15, 123. |
| [90] | Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K. T., Ioannidis, J. P., Campbell, H., & Theodoratou, E. (2017) Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomized controlled trials, and Mendelian randomization studies. BMJ, 357, j2376. |
| [91] | Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda-Sanabria, J. Coyfish, M., Guillo, S., Jansen, T. L., Jansens, H., Lioté, F., Mallen, C., Nuki, G., Perez-Ruiz, F., Pimentao, J., Punzi, L., Pywell, T., So, A., Tausche, A. K., Uhlig, T., Zavada, J., Zhang, W., Tubach, F., & Bardin, T. (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis, 76, 29-42. |
| [92] | The Ministry of Health, Labour and Welfare. (2021) Trends in death rates for leading causes of death [Internet]. Available from: https://www.mhlw.go.jp/toukei/list/81-1a.html. |
| [93] | van Durme, C., van Echteld, I. A. A. M., Falzon, L., Aletaha, D., van der Heijde, D. M. F. M., & Landewé, R. B. (2014) Cardiovascular risk factors and comorbidities in patients with hyperuricemia and /or gout: A systematic review in the literature. J Rheumatol, 92, 9-14. |
| [94] | Clarson, L. E., Chandratre, P., Hider, S. L., Belcher, J., Heneghan, C., Roddy, E., & Mallen, C. D. (2015) Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis. Eur J Prev Cardiol, 22, 335-343. |
| [95] | Perez-Ruiz, F., Martinez-Indart, I., Carmona, I., Herrero-Beites, A. M., Pijcan, J. I., & Krishnan, E. (2014) Tophaceous gout and high level of hyperuricemia are both associated with increased risk of mortality with gout. Ann Rheum Dis, 73, 177-183. |
| [96] | Clarson, L. E., Hider, S. L., Belcher, J., Heneghan, C., Roddy, E., & Mallen, C. D. (2015) Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis, 74, 642-647. |
| [97] | Choi, H. K., & Curhan, G. (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 116, 894-900. |
| [98] | The Ministry of Health, Labour and Welfare and Ministry of Agriculture, Forestry and Fisheries. 2010, Japanese Food Guide Spinning Top, Tokyo. [Internet]. Available from: http://www.maff.go.jp/j/balance_guide/b_sizai/attach/pdf/index-56.pdf. |
| [99] | Tsuduki, T. (2019) The Japanese diet that is effective for health maintenance. J Integr Stud Diet Habits, 30, 71-78 (in Japanese). |
| [100] | Kurotani, K., Akter, S., Kashino, I., Goto, A., Mizoue, T., Noda, M., Sasazuki, S., Sawada, N., Tsugane, S; Japan Public Health Center based Prospective Study Group. (2016) Quality of diet and mortality among Japanese men and women: Japan Public Health Center based prospective study. BMJ, 352, i1209. |
APA Style
Takashi Koguchi. (2021). Modification of Dietary Habits for Prevention of Gout in Japanese People: Gout and the Japanese Diet. American Journal of Health Research, 9(5), 117-127. https://doi.org/10.11648/j.ajhr.20210905.12
ACS Style
Takashi Koguchi. Modification of Dietary Habits for Prevention of Gout in Japanese People: Gout and the Japanese Diet. Am. J. Health Res. 2021, 9(5), 117-127. doi: 10.11648/j.ajhr.20210905.12
AMA Style
Takashi Koguchi. Modification of Dietary Habits for Prevention of Gout in Japanese People: Gout and the Japanese Diet. Am J Health Res. 2021;9(5):117-127. doi: 10.11648/j.ajhr.20210905.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajhr.20210905.12,
author = {Takashi Koguchi},
title = {Modification of Dietary Habits for Prevention of Gout in Japanese People: Gout and the Japanese Diet},
journal = {American Journal of Health Research},
volume = {9},
number = {5},
pages = {117-127},
doi = {10.11648/j.ajhr.20210905.12},
url = {https://doi.org/10.11648/j.ajhr.20210905.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20210905.12},
abstract = {Gout is the most common form of inflammatory arthritis, and it is characterized by the deposition of monosodium urate crystals that form in the presence of increased uric acid concentrations. A high serum uric acid concentration (hyperuricemia) is frequently associated with gout. The burden of gout has increased between 1990 and 2017 globally. In Japan, most of gout patients are adults, and the number of gout patients are higher in men than in women. The prevalence of gout has increased markedly since the 1960s. The Japanese Society of Gout and Uric & Nucleic Acids has stated that an increase in hyperuricemia and gout patients is attributed to changes in environmental factors (e.g., purine intake, fructose intake, meat and visceral intake, alcohol consumption, strenuous muscle exercise, stress, obesity) rather than genetic factors. The Japanese economy revived to pre-World War II levels around 1955 and the eating habits in 1960s became stable. The menu of Japanese food has been rapidly expanded with a variety of dishes due to the westernization of meals from 1955 to 1965. Compared to the Japanese diet in 1950, in the Japanese diet in 2016, consumption of rice and potatoes decreased, whereas intake of wheat, legumes, seeds and nuts, seaweed, vegetables, fruit, meat, seafood, eggs, milk and dairy products, oils and fats, seasoning and spices increased. This phenomenon is thought to be attributed to the westernization of the Japanese diet since 1955. Recognizing changes in the Japanese diet are important for dietary habits modification to prevent gout in Japanese people. The objective of this article is to propose a preventive method for gout through the evaluation of recent dietary habits in Japanese people. This article suggests that changes in the Japanese diet are possible to be one of the factors contributing to the increase in the number of gout patients in Japan.},
year = {2021}
}
TY - JOUR T1 - Modification of Dietary Habits for Prevention of Gout in Japanese People: Gout and the Japanese Diet AU - Takashi Koguchi Y1 - 2021/09/10 PY - 2021 N1 - https://doi.org/10.11648/j.ajhr.20210905.12 DO - 10.11648/j.ajhr.20210905.12 T2 - American Journal of Health Research JF - American Journal of Health Research JO - American Journal of Health Research SP - 117 EP - 127 PB - Science Publishing Group SN - 2330-8796 UR - https://doi.org/10.11648/j.ajhr.20210905.12 AB - Gout is the most common form of inflammatory arthritis, and it is characterized by the deposition of monosodium urate crystals that form in the presence of increased uric acid concentrations. A high serum uric acid concentration (hyperuricemia) is frequently associated with gout. The burden of gout has increased between 1990 and 2017 globally. In Japan, most of gout patients are adults, and the number of gout patients are higher in men than in women. The prevalence of gout has increased markedly since the 1960s. The Japanese Society of Gout and Uric & Nucleic Acids has stated that an increase in hyperuricemia and gout patients is attributed to changes in environmental factors (e.g., purine intake, fructose intake, meat and visceral intake, alcohol consumption, strenuous muscle exercise, stress, obesity) rather than genetic factors. The Japanese economy revived to pre-World War II levels around 1955 and the eating habits in 1960s became stable. The menu of Japanese food has been rapidly expanded with a variety of dishes due to the westernization of meals from 1955 to 1965. Compared to the Japanese diet in 1950, in the Japanese diet in 2016, consumption of rice and potatoes decreased, whereas intake of wheat, legumes, seeds and nuts, seaweed, vegetables, fruit, meat, seafood, eggs, milk and dairy products, oils and fats, seasoning and spices increased. This phenomenon is thought to be attributed to the westernization of the Japanese diet since 1955. Recognizing changes in the Japanese diet are important for dietary habits modification to prevent gout in Japanese people. The objective of this article is to propose a preventive method for gout through the evaluation of recent dietary habits in Japanese people. This article suggests that changes in the Japanese diet are possible to be one of the factors contributing to the increase in the number of gout patients in Japan. VL - 9 IS - 5 ER -
Email: